Effect of various anticancer agents on DNA polymerase.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D001853:Bone Marrow / Q000201:enzymology; D006528:Carcinoma, Hepatocellular / Q000201:enzymology; D003597:Cytosine Nucleotides / Q000378:metabolism; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003854:Deoxyribonucleotides / Q000378:metabolism; D005472:Fluorouracil / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms; D008115:Liver Regeneration; D008937:Mitomycins / Q000494:pharmacology; D009374:Neoplasms, Experimental / Q000201:enzymology; D051381:Rats; D012293:Rifampin / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003597:Cytosine Nucleotides; D004273:DNA, Neoplasm; D003854:Deoxyribonucleotides; D008937:Mitomycins; D014316:Tritium; D001761:Bleomycin; D003609:Dactinomycin; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D004254:DNA Nucleotidyltransferases; D005472:Fluorouracil; D013936:Thymidine; D012293:Rifampin